EYPT insider transaction filings
EyePoint, Inc. — 43 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-18. Screen EYPT transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | Zaderej Karen L. — Director | Purchase (P): 10,600 @ $4.93 | EDGAR |
| 2026-07-14 | 4 | Duker Jay S. — President and CEO, Director | Option exercise (M): 16,667 @ $0 · Tax withholding (F): 8,059 @ $14.72 · Option exercise (M): 16,667 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Ribeiro Ramiro — Chief Medical Officer | Option exercise (M): 2,437 @ $8.26 · Option exercise (M): 2,438 @ $8.26 · Sale (S): 2,437 @ $15 · Sale (S): 2,438 @ $15.02 · Option exercise (M): 2,437 (derivative) @ $0 · Option exercise (M): 2,438 (derivative) @ $0 | EDGAR |
| 2026-05-27 | 4 | Elston George — Chief Financial Officer | Option exercise (M): 7,500 @ $0 · Tax withholding (F): 3,627 @ $12.93 · Option exercise (M): 7,500 (derivative) @ $0 | EDGAR |
| 2026-04-20 | 4 | Ribeiro Ramiro — Chief Medical Officer | Option exercise (M): 2,437 @ $8.26 · Sale (S): 2,437 @ $15 · Option exercise (M): 2,437 (derivative) @ $0 | EDGAR |
| 2026-03-24 | 4 | Duker Jay S. — President and CEO, Director | Other (J): 76,766 @ $13.11 · Other (J): 76,766 @ $13.11 · Other (J): 52,500 (derivative) @ $8.75 · Other (J): 52,500 (derivative) @ $8.75 · Other (J): 97,500 (derivative) @ $9.57 · Other (J): 97,500 (derivative) @ $9.57 | EDGAR |
| 2026-03-16 | 4 | Duker Jay S. — President and CEO, Director | Purchase (P): 1,500 @ $13.15 | EDGAR |
| 2026-03-06 | 4 | Elston George — Chief Financial Officer | Gift (G): 5,000 @ $0 · Gift (G): 5,000 @ $0 | EDGAR |
| 2026-03-05 | 4 | Ribeiro Ramiro — Chief Medical Officer | Option exercise (M): 2,438 @ $8.26 · Sale (S): 2,438 @ $17.87 · Option exercise (M): 2,438 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | Ribeiro Ramiro — Chief Medical Officer | Option exercise (M): 2,437 @ $8.26 · Sale (S): 2,437 @ $15 · Option exercise (M): 2,437 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Ribeiro Ramiro — Chief Medical Officer | Option exercise (M): 29,250 @ $8.26 · Sale (S): 42,544 @ $17.10 · Option exercise (M): 29,250 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Duker Jay S. — President and CEO, Director | Option exercise (M): 20,793 @ $0 · Tax withholding (F): 10,054 @ $16.86 · Option exercise (M): 20,793 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Lurker Nancy — Director | Option exercise (M): 75,133 @ $0 · Option exercise (M): 75,133 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Elston George — Chief Financial Officer | Option exercise (M): 15,285 @ $0 · Tax withholding (F): 4,487 @ $16.86 · Option exercise (M): 15,285 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Sanders Reginald J. — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Ribeiro Ramiro — Chief Medical Officer | Option exercise (M): 19,667 @ $0 · Tax withholding (F): 6,373 @ $17.48 · Grant/award (A): 85,700 (derivative) @ $0 · Grant/award (A): 171,400 (derivative) @ $0 · Option exercise (M): 19,667 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Duty Stuart — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Duker Jay S. — President and CEO, Director | Option exercise (M): 65,000 @ $0 · Tax withholding (F): 23,447 @ $17.48 · Option exercise (M): 30,000 @ $0 · Tax withholding (F): 14,505 @ $17.43 · Grant/award (A): 165,000 (derivative) @ $0 · Grant/award (A): 331,000 (derivative) @ $0 · +2 more | EDGAR |
| 2026-01-06 | 4 | Zaderej Karen L. — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Landis John B. — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Lurker Nancy — Director | Option exercise (M): 12,666 @ $0 · Grant/award (A): 40,000 (derivative) @ $0 · Option exercise (M): 12,666 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Elston George — Chief Financial Officer | Option exercise (M): 19,667 @ $0 · Tax withholding (F): 6,324 @ $17.48 · Option exercise (M): 15,000 @ $0 · Tax withholding (F): 4,403 @ $17.43 · Grant/award (A): 63,000 (derivative) @ $0 · Grant/award (A): 126,000 (derivative) @ $0 · +2 more | EDGAR |
| 2026-01-06 | 4 | DICICCO WENDY F — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | ANDO GORAN — Director | Grant/award (A): 41,500 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Hassan Fred — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | Elston George — Chief Financial Officer | Gift (G): 5,000 @ $0 · Gift (G): 5,000 @ $0 | EDGAR |
| 2025-12-08 | 4 | Cormorant Asset Management, LP Cormorant Global Healthcare Master Fund, LP Chen Bihua | Sale (S): 60,000 @ $15.70 | EDGAR |
| 2025-12-05 | 4 | Lurker Nancy — Director | Sale (S): 9,300 @ $15.11 | EDGAR |
| 2025-12-01 | 4 | Lurker Nancy — Director | Sale (S): 200 @ $14.95 · Sale (S): 500 @ $14.95 | EDGAR |
| 2025-11-12 | 4 | Ribeiro Ramiro — Chief Medical Officer | Sale (S): 2,722 @ $11.61 | EDGAR |
| 2025-09-22 | 4 | Elston George — Chief Financial Officer | Gift (G): 20,000 @ $0 · Gift (G): 20,000 @ $0 | EDGAR |
| 2025-07-11 | 4 | Zaderej Karen L. — Director | Option exercise (M): 2,000 @ $0 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2025-07-11 | 4 | Lurker Nancy — Director | Option exercise (M): 11,111 @ $0 · Option exercise (M): 11,111 (derivative) @ $0 | EDGAR |
| 2025-07-11 | 4 | Duker Jay S. — President and CEO, Director | Option exercise (M): 16,667 @ $0 · Tax withholding (F): 7,688 @ $11.06 · Option exercise (M): 16,667 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Lurker Nancy — Director | Gift (G): 31,165 (derivative) @ $0 · Gift (G): 31,165 (derivative) @ $0 · Gift (G): 55,000 (derivative) @ $0 · Gift (G): 55,000 (derivative) @ $0 · Gift (G): 103,308 (derivative) @ $0 · Gift (G): 103,308 (derivative) @ $0 · +4 more | EDGAR |
| 2025-06-25 | 4 | Duker Jay S. — President and CEO, Director | Other (J): 56,665 @ $8.21 | EDGAR |
| 2025-05-27 | 4 | Elston George — Chief Financial Officer | Option exercise (M): 7,500 @ $0 · Tax withholding (F): 2,202 @ $5.68 · Option exercise (M): 7,500 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | Zaderej Karen L. — Director | Purchase (P): 5,000 @ $5.81 · Purchase (P): 5,000 @ $5.99 | EDGAR |
| 2025-05-15 | 4 | Zaderej Karen L. — Director | Purchase (P): 5,000 @ $5.42 · Purchase (P): 5,000 @ $5.47 | EDGAR |
| 2025-03-20 | 4 | Duker Jay S. — President and CEO, Director | Other (J): 20,000 @ $6.16 | EDGAR |
| 2025-02-11 | 4 | Elston George — Chief Financial Officer | Option exercise (M): 5,834 @ $0 · Option exercise (M): 5,834 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | Lurker Nancy — Director | Option exercise (M): 20,000 @ $0 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | Duker Jay S. — President and CEO, Director | Option exercise (M): 7,000 @ $0 · Tax withholding (F): 2,055 @ $6.50 · Option exercise (M): 7,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — EyePoint, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-17 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-30 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-17 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-22 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-14 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-13 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-20 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-03-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=EYPT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →